Raju Ajay 4

What Happened
Raju Ajay, a director of Medicus Pharma Ltd. (MDCX), was granted 50,000 derivative securities (reported as an award) on June 3, 2026. The Form 4 reports the acquisition at $0.00 (reporting a $0 value on the filing). This is an equity award (not a sale or market purchase) and is typically part of compensation or director equity programs rather than an outright cash purchase.

Key Details

• Transaction date: 2026-06-03; Form 4 filed: 2026-06-04 (appears timely).
• Transaction type/code: A (Award/Grant) — derivative securities. Reported price: $0.00; reported total value: $0.
• Quantity: 50,000 shares/options granted.
• Vesting: The option is scheduled to vest quarterly in four equal installments over one year (per footnote).
• Shares owned after transaction: not disclosed in the supplied filing details.
• No indication of immediate exercise or sale in this filing.

Context
This was an award/grant of derivative securities (likely stock options or restricted stock units) to a company director. Such grants are common as compensation and do not by themselves signal buying or selling activity in the open market. Because the award vests over a year, the economic benefit to the insider depends on future vesting and any exercise terms not detailed in the Form 4 excerpt.